#United States #Greenwich #L Catterton #Thorne #Procter & Gamble

L Catterton's Strategic Move

L Catterton, the largest global investment firm focused on consumer brands, has announced a major transaction with the definitive agreement to sell its portfolio company, Thorne, to Procter & Gamble (P&G) for a staggering $3.8 billion. This strategic decision was made public on August 4, 2026, and indicates a powerful shift in the health and wellness marketplace.

Accelerating Growth in Health and Wellness

Thorne, a leader in science-backed health solutions, has enjoyed significant growth and recognition, thanks in part to L Catterton’s support. The partnership, which took root when L Catterton invested in Thorne in October 2023, has proven successful in fortifying Thorne’s position as a trusted brand in the wellness sector. Under L Catterton’s guidance, Thorne not only expanded its market reach but also enhanced its operational capabilities.

L Catterton’s strategic decisions were rooted in extensive research into the Vitamins, Minerals, and Supplements (VMS) sector. The firm discerned a substantial change in consumer behavior—an increased preference for proactive and clinically-backed wellness products. This insight led to the identification of Thorne as a brand aptly suited to meet the rising consumer demand for reliable health solutions.

Investment and Development

Throughout their partnership, L Catterton made significant investments aimed at accelerating Thorne's growth trajectory, including:

• - Recruiting a High-Caliber Leadership Team: The new leadership helped navigate the complexities of health and wellness space effectively.
• - Enhancing Marketing and Commercial Strategies: These efforts allowed Thorne to better reach a broader audience.
• - Investment in R&D: Continuous support for scientific research improved product quality and innovation, keeping Thorne at the forefront of wellness solutions.
• - Strengthening Manufacturing and Quality Processes: Investment in technology and operational systems helped bolster Thorne's product reliability.

A notable achievement during this period was the development of a proprietary AI wellness advisor that enhances the consumer experience by providing personalized health insights. This innovation represents Thorne's commitment to leveraging technology to serve both healthcare practitioners and consumers better.

Statements from Leadership

Marc Magliacano, Managing Partner at L Catterton, expressed pride in the partnership, stating that their collaboration reflects L Catterton's core mission: to identify significant consumer trends and partner with leading brands for growth fulfillment. He emphasized Thorne’s unique positioning in the wellness sphere, citing consumer demand for clinically-backed health solutions.

Rajan Shah, another partner at L Catterton, reinforced the long-term vision shared with Thorne’s leadership, highlighting the commitment to building on the brand’s established trust among both practitioners and customers.

On the other hand, Colin Watts, CEO of Thorne, praised L Catterton for their unwavering support, focusing on the enhancements made across digital platforms, supply chain, and scientific integrity. He acknowledged the significant contributions L Catterton made to prepare Thorne for a promising future, especially as it transitions to new ownership.

The Road Ahead

As Thorne embarks on this new chapter under Procter & Gamble’s stewardship, the deal is anticipated to close by the end of 2026. Financial advisory roles were filled by Perella Weinberg Partners and Canaccord Genuity for Thorne, while Kirkland & Ellis and Jones Day provided legal counsel for the respective parties involved.

This strategic acquisition signals an exciting future for both Thorne and Procter & Gamble, with the potential to reshape the wellness industry landscape and meet the escalating demand for trusted health solutions.